Other Species / Isoforms
  SEPT7 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y30-p
QQKNLEGyVGFANLP
0 183
SEPT7 (human) QQKNLEGyVGFANLP Y30-p
SEPT7 iso2 (human) QQKNLEGyVGFANLP Y29-p
SEPT7 (mouse) QPKNLEGyVGFANLP Y29-p
SEPT7 (rat) QPKNLEGyVGFANLP Y29-p
Y41-p
ANLPNQVyRKsVKRG
0 14
SEPT7 (human) ANLPNQVyRKsVKRG Y41-p
SEPT7 iso2 (human) ANLPNQVYRKSVKRG Y40
SEPT7 (mouse) ANLPNQVYRKSVKRG Y40
SEPT7 (rat) ANLPNQVYRKSVKRG Y40
S44-p
PNQVyRKsVKRGFEF
0 5
SEPT7 (human) PNQVyRKsVKRGFEF S44-p
SEPT7 iso2 (human) PNQVYRKSVKRGFEF S43
SEPT7 (mouse) PNQVYRKSVKRGFEF S43
SEPT7 (rat) PNQVYRKSVKRGFEF S43
Y76
SLFLTDLYsPEyPGP
0 7
SEPT7 (human) SLFLTDLYsPEyPGP Y76
SEPT7 iso2 (human) SLFLTDLYSPEYPGP Y75
SEPT7 (mouse) SLFLTDLYsPEYPGP Y75
SEPT7 (rat) SLFLTDLysPEYPGP Y75-p
S77-p
LFLTDLYsPEyPGPS
0 6
SEPT7 (human) LFLTDLYsPEyPGPS S77-p
SEPT7 iso2 (human) LFLTDLYSPEYPGPS S76
SEPT7 (mouse) LFLTDLYsPEYPGPS S76-p
SEPT7 (rat) LFLTDLysPEYPGPS S76-p
Y80-p
TDLYsPEyPGPSHRI
0 4
SEPT7 (human) TDLYsPEyPGPSHRI Y80-p
SEPT7 iso2 (human) TDLYSPEYPGPSHRI Y79
SEPT7 (mouse) TDLYsPEYPGPSHRI Y79
SEPT7 (rat) TDLysPEYPGPSHRI Y79
K89-ub
GPSHRIKkTVQVEQS
0 2
SEPT7 (human) GPSHRIKkTVQVEQS K89-ub
SEPT7 iso2 (human) GPSHRIKKTVQVEQS K88
SEPT7 (mouse) GPSHRIKKTVQVEQS K88
SEPT7 (rat) GPSHRIKKTVQVEQS K88
K97
TVQVEQSKVLIKEGG
0 1
SEPT7 (human) TVQVEQSKVLIKEGG K97
SEPT7 iso2 (human) TVQVEQSKVLIKEGG K96
SEPT7 (mouse) TVQVEQSKVLIKEGG K96
SEPT7 (rat) TVQVEQSkVLIKEGG K96-ac
K97-ub
TVQVEQSkVLIKEGG
0 5
SEPT7 (human) TVQVEQSkVLIKEGG K97-ub
SEPT7 iso2 (human) TVQVEQSKVLIKEGG K96
SEPT7 (mouse) TVQVEQSkVLIKEGG K96-ub
SEPT7 (rat) TVQVEQSKVLIKEGG K96
Y141-p
IDSKFEDyLNAESRV
0 8
SEPT7 (human) IDSKFEDyLNAESRV Y141-p
SEPT7 iso2 (human) IDSKFEDYLNAESRV Y140
SEPT7 (mouse) IDSKFEDyLNAESRV Y140-p
SEPT7 (rat) IDSKFEDYLNAESRV Y140
K173-ub
APSGHGLkPLDIEFM
1 0
SEPT7 (human) APSGHGLkPLDIEFM K173-ub
SEPT7 iso2 (human) APSGHGLKPLDIEFM K172
SEPT7 (mouse) APSGHGLKPLDIEFM K172
SEPT7 (rat) APSGHGLKPLDIEFM K172
K181-ac
PLDIEFMkRLHEkVN
0 2
SEPT7 (human) PLDIEFMkRLHEkVN K181-ac
SEPT7 iso2 (human) PLDIEFMKRLHEKVN K180
SEPT7 (mouse) PLDIEFMkRLHEkVN K180-ac
SEPT7 (rat) PLDIEFMKRLHEkVN K180
K181-ub
PLDIEFMkRLHEkVN
1 0
SEPT7 (human) PLDIEFMkRLHEkVN K181-ub
SEPT7 iso2 (human) PLDIEFMKRLHEKVN K180
SEPT7 (mouse) PLDIEFMKRLHEkVN K180
SEPT7 (rat) PLDIEFMKRLHEkVN K180
K186-ac
FMkRLHEkVNIIPLI
0 2
SEPT7 (human) FMkRLHEkVNIIPLI K186-ac
SEPT7 iso2 (human) FMKRLHEKVNIIPLI K185
SEPT7 (mouse) FMkRLHEKVNIIPLI K185
SEPT7 (rat) FMKRLHEkVNIIPLI K185-ac
K186-ub
FMkRLHEkVNIIPLI
0 6
SEPT7 (human) FMkRLHEkVNIIPLI K186-ub
SEPT7 iso2 (human) FMKRLHEKVNIIPLI K185
SEPT7 (mouse) FMkRLHEkVNIIPLI K185-ub
SEPT7 (rat) FMKRLHEKVNIIPLI K185
K195-ub
NIIPLIAkADtLTPE
0 1
SEPT7 (human) NIIPLIAkADtLTPE K195-ub
SEPT7 iso2 (human) NIIPLIAKADTLTPE K194
SEPT7 (mouse) NIIPLIAKADtLTPE K194
SEPT7 (rat) NIIPLIAKADTLTPE K194
T198-p
PLIAkADtLTPEECQ
0 2
SEPT7 (human) PLIAkADtLTPEECQ T198-p
SEPT7 iso2 (human) PLIAKADTLTPEECQ T197
SEPT7 (mouse) PLIAKADtLTPEECQ T197-p
SEPT7 (rat) PLIAKADTLTPEECQ T197
K208-ac
PEECQQFkKQIMkEI
0 50
SEPT7 (human) PEECQQFkKQIMkEI K208-ac
SEPT7 iso2 (human) PEECQQFKKQIMKEI K207
SEPT7 (mouse) PEECQQFkKQIMkEI K207-ac
SEPT7 (rat) PEECQQFkKQIMKEI K207-ac
K208-ub
PEECQQFkKQIMkEI
0 2
SEPT7 (human) PEECQQFkKQIMkEI K208-ub
SEPT7 iso2 (human) PEECQQFKKQIMKEI K207
SEPT7 (mouse) PEECQQFkKQIMkEI K207-ub
SEPT7 (rat) PEECQQFKKQIMKEI K207
K213-ac
QFkKQIMkEIQEHkI
0 1
SEPT7 (human) QFkKQIMkEIQEHkI K213-ac
SEPT7 iso2 (human) QFKKQIMKEIQEHKI K212
SEPT7 (mouse) QFkKQIMKEIQEHKI K212
SEPT7 (rat) QFkKQIMKEIQGHKI K212
K213-ub
QFkKQIMkEIQEHkI
0 5
SEPT7 (human) QFkKQIMkEIQEHkI K213-ub
SEPT7 iso2 (human) QFKKQIMKEIQEHKI K212
SEPT7 (mouse) QFkKQIMkEIQEHKI K212-ub
SEPT7 (rat) QFkKQIMKEIQGHKI K212
K219-ub
MkEIQEHkIkIyEFP
0 2
SEPT7 (human) MkEIQEHkIkIyEFP K219-ub
SEPT7 iso2 (human) MKEIQEHKIKIYEFP K218
SEPT7 (mouse) MkEIQEHKIKIYEFP K218
SEPT7 (rat) MKEIQGHKIkIyEFP K218
K221
EIQEHkIKIyEFPEt
0 1
SEPT7 (human) EIQEHkIKIyEFPEt K221
SEPT7 iso2 (human) EIQEHKIKIYEFPET K220
SEPT7 (mouse) EIQEHKIKIYEFPEt K220
SEPT7 (rat) EIQGHKIkIyEFPEt K220-ac
K221-ub
EIQEHkIkIyEFPEt
0 1
SEPT7 (human) EIQEHkIkIyEFPEt K221-ub
SEPT7 iso2 (human) EIQEHKIKIYEFPET K220
SEPT7 (mouse) EIQEHKIKIYEFPEt K220
SEPT7 (rat) EIQGHKIKIyEFPEt K220
Y223-p
QEHkIkIyEFPEtDD
0 4
SEPT7 (human) QEHkIkIyEFPEtDD Y223-p
SEPT7 iso2 (human) QEHKIKIYEFPETDD Y222
SEPT7 (mouse) QEHKIKIYEFPEtDD Y222
SEPT7 (rat) QGHKIkIyEFPEtDD Y222-p
T228-p
kIyEFPEtDDEEENk
Upstream
0 55
Kinase, in vitro:
  • Chk1 (human)
Treatment
  • ischemia
SEPT7 (human) kIyEFPEtDDEEENk T228-p
SEPT7 iso2 (human) KIYEFPETDDEEENK T227
SEPT7 (mouse) KIYEFPEtDDEEENk T227-p
SEPT7 (rat) kIyEFPEtDDEEENk T227-p
K235
tDDEEENKLVkkIKD
0 1
SEPT7 (human) tDDEEENKLVkkIKD K235
SEPT7 iso2 (human) TDDEEENKLVKKIKD K234
SEPT7 (mouse) tDDEEENKLVKKIKD K234
SEPT7 (rat) tDDEEENkLVKKIKD K234-ac
K235-ub
tDDEEENkLVkkIKD
0 8
SEPT7 (human) tDDEEENkLVkkIKD K235-ub
SEPT7 iso2 (human) TDDEEENKLVKKIKD K234
SEPT7 (mouse) tDDEEENkLVKKIKD K234-ub
SEPT7 (rat) tDDEEENKLVKKIKD K234
K238-ub
EEENkLVkkIKDRLP
0 1
SEPT7 (human) EEENkLVkkIKDRLP K238-ub
SEPT7 iso2 (human) EEENKLVKKIKDRLP K237
SEPT7 (mouse) EEENkLVKKIKDRLP K237
SEPT7 (rat) EEENkLVKKIKDRLP K237
K239-ub
EENkLVkkIKDRLPL
0 1
SEPT7 (human) EENkLVkkIKDRLPL K239-ub
SEPT7 iso2 (human) EENKLVKKIKDRLPL K238
SEPT7 (mouse) EENkLVKKIKDRLPL K238
SEPT7 (rat) EENkLVKKIKDRLPL K238
K260-ub
TIIEVNGkRVRGRQY
0 2
SEPT7 (human) TIIEVNGkRVRGRQY K260-ub
SEPT7 iso2 (human) TIIEVNGKRVRGRQY K259
SEPT7 (mouse) TIIEVNGkRVRGRQY K259-ub
SEPT7 (rat) TIIEVNGKRVRGRQY K259
K298-ub
RTHMQDLkDVTNNVH
0 4
SEPT7 (human) RTHMQDLkDVTNNVH K298-ub
SEPT7 iso2 (human) RTHMQDLKDVTNNVH K297
SEPT7 (mouse) RTHMQDLkDVTNNVH K297-ub
SEPT7 (rat) RTHMQDLKDVTNNVH K297
Y306-p
DVTNNVHyENyRSRk
0 1
SEPT7 (human) DVTNNVHyENyRSRk Y306-p
SEPT7 iso2 (human) DVTNNVHYENYRSRK Y305
SEPT7 (mouse) DVTNNVHYENYRSRk Y305
SEPT7 (rat) DVTNNVHYENyRSRK Y305
Y309-p
NNVHyENyRSRkLAA
0 9
SEPT7 (human) NNVHyENyRSRkLAA Y309-p
SEPT7 iso2 (human) NNVHYENYRSRKLAA Y308
SEPT7 (mouse) NNVHYENYRSRkLAA Y308
SEPT7 (rat) NNVHYENyRSRKLAA Y308-p
K313-ub
yENyRSRkLAAVtyN
0 3
SEPT7 (human) yENyRSRkLAAVtyN K313-ub
SEPT7 iso2 (human) YENYRSRKLAAVTYN K312
SEPT7 (mouse) YENYRSRkLAAVTyn K312-ub
SEPT7 (rat) YENyRSRKLAAVTyN K312
K313-ac
yENyRSRkLAAVtyN
0 1
SEPT7 (human) yENyRSRkLAAVtyN K313-ac
SEPT7 iso2 (human) YENYRSRKLAAVTYN K312
SEPT7 (mouse) YENYRSRKLAAVTyn K312
SEPT7 (rat) YENyRSRKLAAVTyN K312
T318-p
SRkLAAVtyNGVDNN
0 21
SEPT7 (human) SRkLAAVtyNGVDNN T318-p
SEPT7 iso2 (human) SRKLAAVTYNGVDNN T317
SEPT7 (mouse) SRkLAAVTynGVDNN T317
SEPT7 (rat) SRKLAAVTyNGVDNN T317
Y319-p
RkLAAVtyNGVDNNk
Upstream
1 471
Treatment
  • ephrin_B1
  • erlotinib
  • gefitinib
  • Su11274
  • U0126
SEPT7 (human) RkLAAVtyNGVDNNk Y319-p
SEPT7 iso2 (human) RKLAAVTYNGVDNNK Y318
SEPT7 (mouse) RkLAAVTynGVDNNk Y318-p
SEPT7 (rat) RKLAAVTyNGVDNNK Y318-p
N320
kLAAVtyNGVDNNkN
0 1
SEPT7 (human) kLAAVtyNGVDNNkN N320
SEPT7 iso2 (human) KLAAVTYNGVDNNKN N319
SEPT7 (mouse) kLAAVTynGVDNNkN N319-ng
SEPT7 (rat) KLAAVTyNGVDNNKN N319
K326-ub
yNGVDNNkNKGQLtk
0 2
SEPT7 (human) yNGVDNNkNKGQLtk K326-ub
SEPT7 iso2 (human) YNGVDNNKNKGQLTK K325
SEPT7 (mouse) ynGVDNNkNKGQLtk K325-ub
SEPT7 (rat) yNGVDNNKNKGQLTK K325
T332-p
NkNKGQLtksPLAQM
0 2
SEPT7 (human) NkNKGQLtksPLAQM T332-p
SEPT7 iso2 (human) NKNKGQLTKSPLAQM T331
SEPT7 (mouse) NkNKGQLtksPLAQM T331-p
SEPT7 (rat) NKNKGQLTKsPLAQM T331
K333-ub
kNKGQLtksPLAQME
0 4
SEPT7 (human) kNKGQLtksPLAQME K333-ub
SEPT7 iso2 (human) KNKGQLTKSPLAQME K332
SEPT7 (mouse) kNKGQLtksPLAQME K332-ub
SEPT7 (rat) KNKGQLTKsPLAQME K332
S334-p
NKGQLtksPLAQMEE
Upstream
0 53
Treatment
  • LRRK2-IN-1
  • nocodazole
SEPT7 (human) NKGQLtksPLAQMEE S334-p
SEPT7 iso2 (human) NKGQLTKSPLAQMEE S333
SEPT7 (mouse) NKGQLtksPLAQMEE S333-p
SEPT7 (rat) NKGQLTKsPLAQMEE S333-p
K352
EHVAKMKKMEMEMEQ
0 1
SEPT7 (human) EHVAKMKKMEMEMEQ K352
SEPT7 iso2 (human) EHVAKMKKMEMEMEQ K351
SEPT7 (mouse) EHVAKMKkMEMEMEQ K351-ub
SEPT7 (rat) EHVAKMKKMEMEMEQ K351
K368-ac
FEMKVKEkVQKLkDS
0 1
SEPT7 (human) FEMKVKEkVQKLkDS K368-ac
SEPT7 iso2 (human) FEMKVKEKVQKLKDS K367
SEPT7 (mouse) FEMKVKEKVQKLkDS K367
SEPT7 (rat) FEMKVKEKVQkLkDS K367
K371
KVKEkVQKLkDSEAE
0 1
SEPT7 (human) KVKEkVQKLkDSEAE K371
SEPT7 iso2 (human) KVKEKVQKLKDSEAE K370
SEPT7 (mouse) KVKEKVQKLkDSEAE K370
SEPT7 (rat) KVKEKVQkLkDSEAE K370-ac
K373
KEkVQKLKDSEAELQ
0 1
SEPT7 (human) KEkVQKLKDSEAELQ K373
SEPT7 iso2 (human) KEKVQKLKDSEAELQ K372
SEPT7 (mouse) KEKVQKLKDSEAELQ K372
SEPT7 (rat) KEKVQkLkDSEAELQ K372-ac
K373-ub
KEkVQKLkDSEAELQ
0 2
SEPT7 (human) KEkVQKLkDSEAELQ K373-ub
SEPT7 iso2 (human) KEKVQKLKDSEAELQ K372
SEPT7 (mouse) KEKVQKLkDSEAELQ K372-ub
SEPT7 (rat) KEKVQkLKDSEAELQ K372
K387-ac
QRRHEQMkkNLEAQH
0 2
SEPT7 (human) QRRHEQMkkNLEAQH K387-ac
SEPT7 iso2 (human) QRRHEQMKKNLEAQH K386
SEPT7 (mouse) QRRHEQMKKNLEAQH K386
SEPT7 (rat) QRRHEQMKKNLEAQH K386
K388-ub
RRHEQMkkNLEAQHk
0 1
SEPT7 (human) RRHEQMkkNLEAQHk K388-ub
SEPT7 iso2 (human) RRHEQMKKNLEAQHK K387
SEPT7 (mouse) RRHEQMKKNLEAQHk K387
SEPT7 (rat) RRHEQMKKNLEAQHk K387
K395-ac
kNLEAQHkELEEKRR
0 2
SEPT7 (human) kNLEAQHkELEEKRR K395-ac
SEPT7 iso2 (human) KNLEAQHKELEEKRR K394
SEPT7 (mouse) KNLEAQHKELEEKRR K394
SEPT7 (rat) KNLEAQHkELEEKRR K394-ac
K395-ub
kNLEAQHkELEEKRR
0 5
SEPT7 (human) kNLEAQHkELEEKRR K395-ub
SEPT7 iso2 (human) KNLEAQHKELEEKRR K394
SEPT7 (mouse) KNLEAQHkELEEKRR K394-ub
SEPT7 (rat) KNLEAQHkELEEKRR K394-ub
K408
RRQFEDEKANWEAQQ
0 1
SEPT7 (human) RRQFEDEKANWEAQQ K408
SEPT7 iso2 (human) RRQFEDEKANWEAQQ K407
SEPT7 (mouse) RRQFEEEKANWEAQQ K407
SEPT7 (rat) RRQFEEEkANWEAQQ K407-ac
K408-ub
RRQFEDEkANWEAQQ
0 2
SEPT7 (human) RRQFEDEkANWEAQQ K408-ub
SEPT7 iso2 (human) RRQFEDEKANWEAQQ K407
SEPT7 (mouse) RRQFEEEkANWEAQQ K407-ub
SEPT7 (rat) RRQFEEEKANWEAQQ K407
N422
QRILEQQNssrtLEK
0 1
SEPT7 (human) QRILEQQNssrtLEK N422
SEPT7 iso2 (human) QRILEQQNSSRTLEK N421
SEPT7 (mouse) QRILEQQnssRtLEK N421-ng
SEPT7 (rat) QRILEQQNSSRtLEK N421
S423-p
RILEQQNssrtLEKN
Upstream
0 16
Treatment
  • angiotensin_2
SEPT7 (human) RILEQQNssrtLEKN S423-p
SEPT7 iso2 (human) RILEQQNSSRTLEKN S422
SEPT7 (mouse) RILEQQnssRtLEKN S422-p
SEPT7 (rat) RILEQQNSSRtLEKN S422
S424-p
ILEQQNssrtLEKNK
0 7
SEPT7 (human) ILEQQNssrtLEKNK S424-p
SEPT7 iso2 (human) ILEQQNSSRTLEKNK S423
SEPT7 (mouse) ILEQQnssRtLEKNK S423-p
SEPT7 (rat) ILEQQNSSRtLEKNK S423
R425-m1
LEQQNssrtLEKNKK
0 1
SEPT7 (human) LEQQNssrtLEKNKK R425-m1
SEPT7 iso2 (human) LEQQNSSRTLEKNKK R424
SEPT7 (mouse) LEQQnssRtLEKNKK R424
SEPT7 (rat) LEQQNSSRtLEKNKK R424
T426-p
EQQNssrtLEKNKKK
Upstream
1 100
Treatment
  • SII_angiotensin_2
SEPT7 (human) EQQNssrtLEKNKKK T426-p
SEPT7 iso2 (human) EQQNSSRTLEKNKKK T425
SEPT7 (mouse) EQQnssRtLEKNKKK T425-p
SEPT7 (rat) EQQNSSRtLEKNKKK T425-p